In summary, this is the first report that characterize the role of PDE4 in the remodeled epidermis of pathological scars such as hypertrophic scar and keloids, showing that PDE4B inhibition could be an attractive target to attenuate the growth of the skin fibrotic lesion. Here, PDE4B is linked to neoplasm.